Results 11 to 20 of about 1,315,331 (224)

Acute Device-Related Thrombus after Watchman Device Implant [PDF]

Case Reports in Cardiology, 2019
Atrial fibrillation is characterized by irregularly irregular heart rhythm with an increased morbidity and mortality. It is associated with an increased risk of thromboembolism due to formation of blood clot in the left atrium.
Muhammad Ajmal, Vijendra Swarup
doaj   +3 more sources

Comparative Endothelialization of the Watchman Plug Device and LACBES Pacifier Occluder after Left Atrial Appendage Closure

Reviews in Cardiovascular Medicine
Background: For patients with nonvalvular atrial fibrillation (NVAF), left atrial appendage closure (LAAC) is an alternative to oral anticoagulants (OACs).
Jing Zhou, Zongqi Zhang, Kandi Zhang, Tiantian Zhang, Qing He, Junfeng Zhang   +5 more
doaj   +2 more sources

Percutaneous Retrieval of a Watchman Device from the Left Ventricle Using a Transarterial Approach [PDF]

JACC: Case Reports, 2019
Left atrial appendage closure device embolization is a rare yet serious complication. The location of the embolized device is a major determinant of the retrieval approach, percutaneous or surgical.
Nikolaos Spilias, MD, Arshneel Kochar, MD, Jayendrakumar Patel, MD, Walid Saliba, MD, Samir Kapadia, MD   +4 more
doaj   +2 more sources

The WATCHMAN Device Review: A New Era for Stroke Prophylaxis. [PDF]

J Community Hosp Intern Med Perspect, 2023
Atrial fibrillation (AF) is a major risk factor for ischemic stroke, accounting for more than 37 million cases worldwide. In AF, the left atrial appendage (LAA) is the most common site of thrombus formation, and its ligation/closure with the WATCHMAN ...
Khan S, Naz H, Khan MSQ, Ullah A, Satti DI, Malik J, Mehmoodi A.   +6 more
europepmc   +2 more sources

Percutaneous retrieval of a dislodged watchman left atrial appendage closure device

Cardiology Plus, 2016
A 46-year-old female underwent left atrial appendage closure (LAAC) with a Watchman LAAC device. During the procedure, the device embolized into the descending aorta. A new device was implanted to the left atrial appendage complete the closure.
Jiangtao Yu, Shaofeng Guan, Manuela Muenzel, Erich Duenninger   +3 more
doaj   +2 more sources

National Yearly Trend of Utilization and Procedural Complication of the Watchman Device in the United States. [PDF]

Cureus, 2022
Background Complication from the Watchman device (Boston Scientific Corp, Marlborough, Massachusetts) is operator-dependent, with the latest EWOLUTION trial showing low complication rates (1.8%) thought to be due to maturing physician experience ...
Shrestha B, Poudel B, Poudel D, Diaz Fraga J.   +3 more
europepmc   +5 more sources

Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial. [PDF]

Circulation, 2021
BACKGROUND Percutaneous closure of the left atrial appendage (LAA) is an alternative to chronic oral anticoagulation to reduce stroke risk in patients with nonvalvular atrial fibrillation.
Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, Gold MR, Hermiller J, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, O'Brien L, Windecker S.   +14 more
europepmc   +3 more sources

Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2023
Background: The Amplatzer Amulet (AA) and Watchman devices (WD) are the 2 most frequently used devices for percutaneous LAA closure globally. Objective: To evaluate the safety and clinical outcomes associated with these 2 devices in patients undergoing ...
Jaiswal V, Ang SP, Shrestha AB, Wajid Z, Endurance EO, Ayoobkhan FS, Khan S, Garimellla V, Huang H, Ghanim M, Song D, Sharma P, Alraies MC, Biswas M.   +13 more
europepmc   +5 more sources

Transesophageal Echocardiography to Diagnose Watchman Device Infection [PDF]

Case, 2020
Christina Thaler, Domenico Calcaterra, Joseph Jensen   +2 more
exaly   +2 more sources

Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

International Journal of Cardiology: Heart & Vasculature, 2022
Background: The Watchman FLX is a device upgrade of the Watchman 2.5 that incorporates several design enhancements intended to simplify left atrial appendage occlusion (LAAO) and improve procedural outcomes. This study compares peri-procedural results of
Ignacio Cruz-González, Francisco Torres Saura, Blanca Trejo-Velasco, José Antonio Fernández Díaz, Ricardo Fajardo Molina, Raquel del Valle-Fernández, Gerardo Moreno Terribas, David Martí Sánchez, José-Ramón López-Mínguez, Ivan Gomez-Blazquez, Juan-Carlos Sanmartin Pena, Javier Botas, Pedro Martin Lorenzo, Jorge Palazuelos, Ramón Albarrán Rincon, Mohsen Mohandes, Felipe-Jose Rodriguez Entem, Gerard Martí, Ernesto Valero, Hipólito Gutiérrez, Ignacio J. Amat-Santos, Luis Nombela-Franco, Pablo Salinas, Luis Teruel, Joan-Antoni Gomez-Hospital, Dabit Arzamendi, Mario Torres Sanabria, Germán Calle Pérez, Dolores Cañadas Pruaño, Armando Pérez de Prado, Tomás Benito González, Eduardo Arroyo-Úcar, Rodrigo Estévez-Loureiro, Berenice Caneiro-Queija, Jose L. Ibañez Criado, Juan M. Ruiz-Nodar   +35 more
doaj   +1 more source